How can you find initial capital and attract new investors?
Experts share their experiences and lessons learned on investing in the cell and gene therapy field. They offer their advice on how to approach investors to form meaningful, long-term partnerships for companies on the path towards bringing a potentially life-changing therapy to patients.
Susan Langer, President & Vice President, Business Development, Stealth Biotech Company
Christine Brennan, Partner, MRL Ventures Fund
Gerry Brunk, Managing Director, Lumira Ventures
Samuel Wu, Managing Director, Acuris Partners
Moderated by: Peter Savas, CEO, LikeMinds